TRANS GENIC GROUP INC.

Transgenic Group Inc. develops, distributes, and licenses genetically modified animals and antibodies in Japan. It operates through two segments: Drug Discovery Support Business and Investment and Consulting Business. The company offers services including glycan synthesis and analysis, non-clinical studies and safety tests for pharmaceuticals, foods, cosmetics, and chemicals, support for bioequivalence tests and clinical trials, hospital support, drug efficacy and pharmacological testing, contract production of genetically modified mice and antibodies, and sales of mouse-related products and research reagents. It also provides advice and support for M&A, business revitalization, and business succession. Formerly known as Trans Genic Inc., it changed its name to Transgenic Group Inc. in October 2024. The company was incorporated in 1998 and is headquartered in Fukuoka City, Japan.